Investigating Notch and related pathways for new biomarkers in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the 5th commonest cause of cancer related death in the UK with a 5-year survival rate of only 4%. This is due to vague symptoms, late presentation and lack of availability of decent biomarkers, making most PDAC unsuitable for curative resections at the time...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leicester
2017
|
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733685 |